Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017150174) PHARMACEUTICAL COMPOSITION CONTAINING 2,4-DIAMINOQUINAZOLINE DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT, AND 2,4-DIAMINOQUINAZOLINE DERIVATIVE HAVING SPECIFIC STRUCTURE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/150174 International Application No.: PCT/JP2017/005318
Publication Date: 08.09.2017 International Filing Date: 14.02.2017
IPC:
A61K 31/517 (2006.01) ,A61P 33/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
517
ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
33
Antiparasitic agents
02
Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
06
Antimalarials
Applicants:
株式会社シンスター・ジャパン SYNSTAR JAPAN CO., LTD. [JP/JP]; 神奈川県小田原市栄町2丁目9番地46号 2-9-46 Sakae-cho, Odawara-shi, Kanagawa 2500011, JP
Inventors:
水川 裕樹 MIZUKAWA, Yuki; JP
伊藤 勇 ITOH, Isamu; JP
井原 正隆 IHARA, Masataka; JP
阪之上 清以紀 SAKANOUE, Seiki; JP
Agent:
特許業務法人太陽国際特許事務所 TAIYO, NAKAJIMA & KATO; 東京都新宿区新宿4丁目3番17号 3-17, Shinjuku 4-chome, Shinjuku-ku, Tokyo 1600022, JP
Priority Data:
2016-05759304.03.2016JP
Title (EN) PHARMACEUTICAL COMPOSITION CONTAINING 2,4-DIAMINOQUINAZOLINE DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT, AND 2,4-DIAMINOQUINAZOLINE DERIVATIVE HAVING SPECIFIC STRUCTURE
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT UN DÉRIVÉ DE 2,4-DIAMINOQUINAZOLINE OU UN DE SES SELS COMME INGRÉDIENT ACTIF, ET DÉRIVÉ DE 2,4-DIAMINOQUINAZOLINE AYANT UNE STRUCTURE SPÉCIFIQUE
(JA) 2,4-ジアミノキナゾリン誘導体又はその塩を有効成分として含有する医薬品組成物、及び、特定の構造を有する2,4-ジアミノキナゾリン誘導体
Abstract:
(EN) Provided is a pharmaceutical composition for the treatment or prevention of Plasmodium diseases, the pharmaceutical composition being characterized by containing at least one quinazoline derivative represented by general formula (I) or a salt thereof.
(FR) L'invention concerne une composition pharmaceutique pour traiter ou prévenir des maladies à Plasmodium, la composition pharmaceutique se caractérisant en ce qu'elle contient au moins un dérivé de quinazoline représenté par la formule générale (I) ou un sel de celui-ci.
(JA) 一般式(I)で表わされるキナゾリン誘導体又はその塩を少なくとも1種を含有することを特徴とするマラリア原虫疾患予防または治療用医薬品組成物。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)